Today, the cost of developing a new drug is higher than ever, driven in large part by improperly designed, untimely, or unnecessary clinical studies. Companies pour money into a development…
Read More
To better understand CDISC standards, the requirements surrounding CDISC, and how Nuventra can assist your team in complying with CDISC standards, we have created a two-part blog on what you need…
Read More
To better understand Pharmacokinetic (PK) CDISC standards, the requirements surrounding PK CDISC standards, and how Nuventra can assist your team in complying with CDISC standards, we have created a two-part blog on…
Read More
This series of blog posts describes some of the benefits of partnering with Nuventra to meet your PK/PD needs in drug development. Automate Population PK/PD Model Selection Population PK/PD is…
Read More
While no one sets out to conduct a clinical study that will not meet its objectives, studies commonly fail to meet their objectives or fail to reach their full potential…
Read More